Market Overview:
The global hospital injectable drugs market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising demand for generic drugs, and growing number of hospitals and clinics. The global hospital injectable drugs market is segmented on the basis of type into generic sterile injectables and sterile intravenous (IV) solutions. The generic sterile injectables segment is expected to grow at a higher CAGR than the sterile IV solutions segment during the forecast period from 2018 to 2030. This can be attributed to factors such as lower prices for generics as compared with branded drugs and increasing preference for them due to their quality standards that are equivalent or better than those of branded products. Oncology is one of the key application segments in this market, owing to rising incidence rates of cancer across the globe coupled with technological advancements in cancer treatments that require use of hospital injectable drugs. Other key application segments include anesthesia, anti-infectives, parenteral nutrition, and cardiovascular diseases (CVDs).
Product Definition:
A hospital injectable drug is a medication that is administered intravenously in a hospital setting. These drugs are used to treat a variety of medical conditions, and they can be lifesaving in some cases. Hospital injectable drugs are important for providing treatment for patients who require immediate care.
Generic Sterile Injectables:
In the pharmaceutical industry, injectables are drugs that are administered by injection. They can be sub- divided into two major categories namely sterile and non-sterile injectables. The demand for generic sterile injectable is expected to grow at a lucrative rate during the forecast period owing to factors such as increasing prevalence of chronic diseases, rising geriatric population base and growing healthcare awareness among people.
Sterile Intravenous (IV) Solutions:
Sterile intravenous (IV) solutions are used to deliver medications and fluids into the patient's body. IV solutions are prepared by mixing the ingredients in water, which is sterile when it is ready for use. The most commonly used IV solutions are given drugs or fluids that help fight infections, replace lost blood volume, and provide hydration to patients who cannot drink enough liquids or whose bodies do not produce enough natural juices.
Application Insights:
On the basis of application, the global hospital injectable drugs market has been segmented into oncology, anesthesia, anti-infectives, parenteral nutrition (PN), cardiovascular diseases and others. PN was estimated as largest revenue generating segment in 2017 owing to increasing prevalence of chronic diseases such as diabetes and kidney disease. Moreover, an increase in number of surgeries coupled with rising geriatric population is expected to drive demand for PN over the forecast period.
Anesthesia is anticipated to be fastest growing application segment during the forecast period due to rise in incidences of accidents & trauma cases requiring surgical procedures for treatment across various regions coupled with high adoption rates for novel techniques such as deep brain stimulation and robot-assisted surgery among other applications which are still under investigation phase.
Regional Analysis:
North America dominated the global hospital injectable drugs market in 2017. The presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare spending and usage rates are some of the factors responsible for its large share. Furthermore, increasing government initiatives to promote the use of generic sterile injectables is also expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving economic conditions in emerging countries such as India & China & Indonesia etcetera in this region which has resulted into an increase in medical tourism especially for surgeries & hospital visits resulting into a boost for these products demand over last few years.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. Hospital injectable drugs are used to treat a wide range of chronic diseases such as cancer, diabetes, and heart disease. As a result, the demand for hospital injectable drugs is expected to grow at a rapid pace in the coming years.
- Technological advancements: The hospital injectable drugs market is witnessing significant technological advancements in terms of product design and formulation. This has led to the development of novel drug delivery systems that offer better patient compliance and safety profiles. Such technological advances are likely to fuel the growth of this market in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hospital Injectable Drugs Market Research Report
By Type
Generic Sterile Injectables, Sterile Intravenous (IV) Solutions
By Application
Oncology, Anesthesia, Anti-Infectives, Parenteral Nutrition, Cardiovascular Diseases
By Companies
Hospira (Pfizer Inc.), Baxter, Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Otsuka, B.Braun, JW Life Science, Auromedics, Sanofi, Gland Pharma, Endo International PLC, Sichuan Kelun Pharmaceutical, Cisen Pharmaceutical, Shijiazhuang No. 4 Pharmaceutical, Shandong Hualu Pharmaceutical, CR Double-Crane
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
152
Number of Tables & Figures
107
Customization Available
Yes, the report can be customized as per your need.
Global Hospital Injectable Drugs Market Report Segments:
The global Hospital Injectable Drugs market is segmented on the basis of:
Types
Generic Sterile Injectables, Sterile Intravenous (IV) Solutions
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Anesthesia, Anti-Infectives, Parenteral Nutrition, Cardiovascular Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hospira (Pfizer Inc.)
- Baxter
- Fresenius Kabi
- Sandoz (Novartis)
- Hikma Pharmaceuticals PLC
- Dr. Reddy’s Laboratories Ltd
- Grifols
- Nichi-Iko Group (Sagent)
- Teva Pharmaceutical
- Otsuka
- B.Braun
- JW Life Science
- Auromedics
- Sanofi
- Gland Pharma
- Endo International PLC
- Sichuan Kelun Pharmaceutical
- Cisen Pharmaceutical
- Shijiazhuang No. 4 Pharmaceutical
- Shandong Hualu Pharmaceutical
- CR Double-Crane
Highlights of The Hospital Injectable Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Generic Sterile Injectables
- Sterile Intravenous (IV) Solutions
- By Application:
- Oncology
- Anesthesia
- Anti-Infectives
- Parenteral Nutrition
- Cardiovascular Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hospital Injectable Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hospital injectable drugs are medications that are injected into a patient's body by a healthcare professional. These drugs can be used to treat a variety of medical conditions, including cancer, heart disease, and other serious illnesses.
Some of the major players in the hospital injectable drugs market are Hospira (Pfizer Inc.), Baxter, Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Otsuka, B.Braun, JW Life Science, Auromedics, Sanofi, Gland Pharma, Endo International PLC, Sichuan Kelun Pharmaceutical, Cisen Pharmaceutical, Shijiazhuang No. 4 Pharmaceutical, Shandong Hualu Pharmaceutical, CR Double-Crane.
The hospital injectable drugs market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hospital Injectable Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hospital Injectable Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hospital Injectable Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hospital Injectable Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hospital Injectable Drugs Market Size & Forecast, 2020-2028
4.5.1 Hospital Injectable Drugs Market Size and Y-o-Y Growth
4.5.2 Hospital Injectable Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Generic Sterile Injectables
5.2.2 Sterile Intravenous (IV) Solutions
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Anesthesia
6.2.3 Anti-Infectives
6.2.4 Parenteral Nutrition
6.2.5 Cardiovascular Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hospital Injectable Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hospital Injectable Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Generic Sterile Injectables
9.6.2 Sterile Intravenous (IV) Solutions
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Anesthesia
9.10.3 Anti-Infectives
9.10.4 Parenteral Nutrition
9.10.5 Cardiovascular Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Generic Sterile Injectables
10.6.2 Sterile Intravenous (IV) Solutions
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Anesthesia
10.10.3 Anti-Infectives
10.10.4 Parenteral Nutrition
10.10.5 Cardiovascular Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Generic Sterile Injectables
11.6.2 Sterile Intravenous (IV) Solutions
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Anesthesia
11.10.3 Anti-Infectives
11.10.4 Parenteral Nutrition
11.10.5 Cardiovascular Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Generic Sterile Injectables
12.6.2 Sterile Intravenous (IV) Solutions
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Anesthesia
12.10.3 Anti-Infectives
12.10.4 Parenteral Nutrition
12.10.5 Cardiovascular Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Generic Sterile Injectables
13.6.2 Sterile Intravenous (IV) Solutions
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Anesthesia
13.10.3 Anti-Infectives
13.10.4 Parenteral Nutrition
13.10.5 Cardiovascular Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hospital Injectable Drugs Market: Competitive Dashboard
14.2 Global Hospital Injectable Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Hospira (Pfizer Inc.)
14.3.2 Baxter
14.3.3 Fresenius Kabi
14.3.4 Sandoz (Novartis)
14.3.5 Hikma Pharmaceuticals PLC
14.3.6 Dr. Reddy’s Laboratories Ltd
14.3.7 Grifols
14.3.8 Nichi-Iko Group (Sagent)
14.3.9 Teva Pharmaceutical
14.3.10 Otsuka
14.3.11 B.Braun
14.3.12 JW Life Science
14.3.13 Auromedics
14.3.14 Sanofi
14.3.15 Gland Pharma
14.3.16 Endo International PLC
14.3.17 Sichuan Kelun Pharmaceutical
14.3.18 Cisen Pharmaceutical
14.3.19 Shijiazhuang No. 4 Pharmaceutical
14.3.20 Shandong Hualu Pharmaceutical
14.3.21 CR Double-Crane
